ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1791

Determining the Effect of CD14 Deficiency on Osteoblastogenesis and Subchondral Bone Remodeling In Mice

Kate Sharp1, Lance Murphy2, Vu Nguyen3, Baofeng Hu4 and Carla Scanzello5, 1University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 3University of Pennsylvania, Phildealphia, 4University of Pennsylvania, Wynnewood, PA, 5University of Pennsylvania, Philadelphia

Meeting: ACR Convergence 2025

Keywords: Bone density, Mesenchymal stem cells, Osteoarthritis, osteoblast

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) is a debilitating disease affecting ~54% of US adults 75 and older. Toll-like receptor 4 (TLR4), and its co-receptor CD14, have been implicated in disease severity and progression. CD14 sensitizes TLR4 to low concentrations of its ligands, including ligand lipopolysaccharide (LPS). Osteoblasts (OB) from the mesenchymal cell (MSC) lineage are not known to express significant levels of CD14 but do express TLR4. As a result, the role of CD14 on OB differentiation has not been fully elucidated. However, the response of OB to LPS has been reported to be multi-faceted and dependent on LPS concentration; the effect may be stimulatory at low concentrations and inhibitory at high concentrations. With this, we aimed to identify the effect of CD14 deficiency on bone remodeling in a murine model of OA in vivo and characterize the effect of low-level, OA-relevant LPS stimulation in vitro.

Methods: We first performed destabilization of the medial meniscus (DMM) or sham surgery on 4-5 C57BL/6 (WT) and CD14KO male mice at 12 wks of age. After 2-, 4-, and 8-wks post-surgery, the knees were processed and stained for alkaline phosphatase (ALP) using ELF 97 fluorescent substrate followed by TOPRO3 nuclear counterstaining. Area of ALP+ staining in the medial tibial subchondral area was quantified and normalized to overall trabecular area. In vitro, MSCs were harvested from 5-7 WT and CD14KO male mice at 12 wks of age. Upon confluency, cells were passaged and cultured for 14d with osteogenic differentiation media (ODMMEM + 10% FBS + ascorbic acid + -glycerophosphate) with or without 1 ng/mL of LPS. After 14d, the cells were stained for ALP and imaged at 10x. Percent area of ALP (+) staining was quantified via Cell Profiler.

Results: Fig. 1A-F depicts representative sections from naïve, sham, and DMM-operated WT and CD14KO mice stained for ALP. At 2wks ALP activity seemed to be increased in the surgical groups of both strains,but no significance differences were observed (Fig. 1G) At 4wks, the area of ALP was increased in both the WT and CD14KO DMM groups compared to either naïve (WT) or sham (CD14KO) controls (Fig 1H). By 8 wks, there was no difference between WT DMM and WT control groups (Fig 1I). However, ALP+ area remained elevated in the CD14KO DMM group compared to both sham controls, and the WT DMM group (Fig 1I). In vitro staining for ALP revealed no significant difference between strains, with or without LPS both qualitatively (Fig. 2A-D) and quantitatively (Fig 2E).

Conclusion: In conclusion, our findings suggest OB density is increased in the remodeling subchondral bone post-DMM injury, and the response of WT and CD14KO mice is similar up to 4 wks. However, by 8 wks, ALP activity in WT DMM mice decreased back to baseline, but remained elevated in the DMM-injured CD14KO mice, suggesting prolonged or delayed OB-genesis in response to DMM in CD14KO mice. Thus far, our in vitro experiments did not reveal an inherent defect in osteoblast differentiation evaluated by ALP staining between strains, either in the presence or absence of low concentrations of LPS. Future experiments will more fully characterize the effects of LPS dosage and of related gene expression to determine whether OB differentiation or activity is altered on WT and CD14KO mice.

Supporting image 1Figure 1: (A-F) Representative images of in vivo ALP activity 4-wks post-surgery. (A) WT Naïve, (B) WT Sham, (C) WT DMM, (D) CD14KO Naïve, (E) CD14KO Sham, (F) CD14KO DMM. (G, H, I) 2, 4, and 8-wk quantification of OB area in the medial subchondral bone region normalized to trabecular area. *p < 0.05, scale bar = 500 µm.

Supporting image 2Figure 2: (A-D) Representative images of in vitro ALP activity after 14 days in cell culture imaged in the Cy5 fluorescent channel at 10x. (A) WT MSCs cultured with ODM. (B) CD14KO MSCs cultured with ODM. (C) WT MSCs treated with ODM + 1 ng/mL of LPS. (D) CD14KO MSCs treated with ODM + LPS. (E) Quantification of % area of ALP normalized by total area.


Disclosures: K. Sharp: None; L. Murphy: None; V. Nguyen: None; B. Hu: None; C. Scanzello: None.

To cite this abstract in AMA style:

Sharp K, Murphy L, Nguyen V, Hu B, Scanzello C. Determining the Effect of CD14 Deficiency on Osteoblastogenesis and Subchondral Bone Remodeling In Mice [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/determining-the-effect-of-cd14-deficiency-on-osteoblastogenesis-and-subchondral-bone-remodeling-in-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/determining-the-effect-of-cd14-deficiency-on-osteoblastogenesis-and-subchondral-bone-remodeling-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology